The Beyond Ageing Project: A selective prevention trial using novel pharmacotherapies in an older age cohort at risk for depressio
- Conditions
- depressioncognitive declineMental Health - DepressionMental Health - Studies of normal psychology, cognitive function and behaviourDiet and Nutrition - Other diet and nutrition disorders
- Registration Number
- ACTRN12610000032055
- Lead Sponsor
- niversity of Sydney
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 205
To be eligible participants must:
- Have provided written informed consent before any trial procedures are undertaken
- Be aged 60 years or older, and
- have a lifetime history of depressive symptoms (defined as a K-10 score ranging from 16 to 29) meaning that participants included in the trial will be at greater risk of depression.
Participants will be excluded if they: - Have a history of stroke/other serious cerebro or cardiovascular illness, neurological, psychiatric or neurodegenerative disease or other significant illness; Show clinically relevant levels of depression on the Patient Health Questionnaire (PHQ-9) at the time of screening or, receive a diagnosis of depression based on the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I) at the time of completing the medical assessment; Are suicidal at the time of screening or at the time of completing the medical assessment; Show abnormal liver function or; Are currently taking anti-depressant medications and it is deemed unadvisable by the trial psychiatrist to cease these medications for the period of the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method